RMTI
Rockwell Medical Inc
NASDAQ: RMTI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.84
+3.21% today
Updated 2026-06-04
Market cap
$27.08M
P/E ratio
—
P/S ratio
0.40x
EPS (TTM)
$-0.15
Dividend yield
—
52W range
$1 – $2
Volume
0.3M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F5.7
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$3.00
+257.82%
12-Month target
—
—
Intrinsic (DCF)
$7.47
Margin of safety
+86.35%
1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ 86.35% below intrinsic value
Risks
- Thin margins at -7.99%
- Negative free cash flow $-592000.00
- Revenue declining -8.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $72.81M | $83.61M | $101.49M | $69.26M | $67.68M |
| Net income | $-18.68M | $-8.44M | $-480000.00 | $-5.31M | $-1.60M |
| EPS | — | — | — | — | $-0.15 |
| Free cash flow | $-17.21M | $-9.70M | $3.19M | $-1.20M | $-592000.00 |
| Profit margin | -25.65% | -10.09% | -0.47% | -7.67% | -7.99% |
Peer comparison
Smart narrative
Rockwell Medical Inc trades at $0.84. Our Smart Value Score of 33/100 indicates the stock is weak. TTM revenue stands at $67.68M. with profit margins at -7.99%. Our DCF model estimates intrinsic value at $7.47.
Frequently asked questions
What is Rockwell Medical Inc's stock price?
Rockwell Medical Inc (RMTI) trades at $0.84, on a P/S of 0.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Rockwell Medical Inc overvalued?
Rockwell Medical Inc carries a Smart Value Score of 33/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $7.47 versus the $0.84 price, a 86.3% margin of safety on a cash flow basis.
What is the price target of Rockwell Medical Inc (RMTI)?
The 12-month analyst consensus target is $3.00, about 257.8% above the current $0.84. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Rockwell Medical Inc (RMTI)?
Our DCF model estimates intrinsic value at $7.47, a +86.3% margin of safety versus today's $0.84. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Rockwell Medical Inc's revenue?
Rockwell Medical Inc's trailing twelve-month revenue is $67.68M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.40x
ROE-15.30%
Beta1.58
50D MA$0.84
200D MA$1.03
Shares out0.04B
Float0.04B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—